Lymphoma,%20T-Cell,%20Cutaneous
Showing 9976 - 10000 of >10,000
Colorectal Liver Metastases Trial in Amsterdam, Leiden (Irreversible electroporation (IRE))
Completed
- Colorectal Liver Metastases
- Irreversible electroporation (IRE)
-
Amsterdam, Noord-Holland, Netherlands
- +2 more
Dec 18, 2022
Acute Myeloid Leukemia, Lymphoblastic Leukemia, Acute Leukemia Trial in Chicago (IM-TMI (3Gy), IM-TMI (6Gy), IM-TMI (9Gy))
Completed
- Acute Myeloid Leukemia
- +4 more
- IM-TMI (3Gy)
- +3 more
-
Chicago, IllinoisUniversity of Illinois at Chicago
May 18, 2021
Lymphoma Trial in United Kingdom (biological, drug, radiation)
Terminated
- Lymphoma
- rituximab
- +5 more
-
Manchester, England, United Kingdom
- +4 more
Dec 16, 2021
ctDNA Methylation for Detecting Ovarian Cancer
Recruiting
- Epithelial Ovarian Cancer
- +8 more
- Methylation assay
-
Beijing, Beijing, ChinaLei Li
Mar 24, 2023
Sickle Cell Disease, Attention Deficit, Cognitive Deficit in Attention Trial (EndeavorRx)
Not yet recruiting
- Sickle Cell Disease
- +2 more
- EndeavorRx
- (no location specified)
Oct 3, 2022
Corneal Endothelial Decompensation, Fuchs' Endothelial Dystrophy Trial in Indianapolis, Grand Rapids (Descemet membrane
Recruiting
- Corneal Endothelial Decompensation
- Fuchs' Endothelial Dystrophy
- Descemet membrane endothelial keratoplasty
-
Indianapolis, Indiana
- +1 more
Oct 3, 2022
Type 2 Diabetes, Multiple Dose Insulin Therapy Trial (Personalized treatment)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Multiple Dose Insulin Therapy
- Personalized treatment
- (no location specified)
Nov 18, 2023
NSCLC Trial in Ann Arbor (Pevonedistat, Docetaxel)
Terminated
- Non-small Cell Lung Cancer
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Dec 16, 2021
Poliomyelitis Trial in Gao'an, Pingxiang (sIPV vaccine /DTaP vaccine, sIPV vaccine /Hepatitis A inactivated vaccine /MMR
Recruiting
- Poliomyelitis
- sIPV vaccine /DTaP vaccine
- sIPV vaccine /Hepatitis A inactivated vaccine /MMR vaccine
-
Gao'an, Jiangxi, China
- +1 more
Jun 20, 2022
Non Small Cell Lung Cancer, Liquid Biopsy, Tyrosine Kinase Inhibitor Trial in Rotterdam
Recruiting
- Non Small Cell Lung Cancer
- +2 more
-
Rotterdam, NetherlandsErasmus MC
Feb 2, 2022
Acute Leukemia, Myelodysplastic Syndrome Trial in Duarte (Hematopoietic Cell Transplantation, Intensity-Modulated Radiation
Recruiting
- Acute Leukemia
- Myelodysplastic Syndrome
- Hematopoietic Cell Transplantation
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 7, 2022
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Australia, United States (ABT-199)
Completed
- Chronic Lymphocytic Leukemia
- Non-Hodgkin Lymphoma
-
Tucson, Arizona
- +9 more
Feb 10, 2022
Esophageal Squamous Cell Carcinomas Trial in Beijing (SI-B001, Irinotecan)
Recruiting
- Esophageal Squamous Cell Carcinomas
-
Beijing, Beijing, ChinaBeijing Cancer Hostital
Mar 14, 2022
Herpes Zoster Hospitalizations in Italy
Not yet recruiting
- Herpes Zoster
- Comorbidities and Coexisting Conditions
- Hospitalization
-
L'Aquila, ItalyUniversity of L'Aquila
Jul 11, 2023
Non Small Cell Lung Cancer Metastatic, Advanced Melanoma Trial in Toronto, Montréal, Québec (FMT + ICI)
Recruiting
- Non Small Cell Lung Cancer Metastatic
- Advanced Melanoma
- FMT + ICI
-
Toronto, Ontario, Canada
- +3 more
Aug 19, 2022
Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced
Completed
- Oral Cancer
- PD-1 inhibitor+carboplatin+albumin-bound paclitaxel
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital
Nov 20, 2023
Pneumococcal Infections Trial in Adelaide (Gamma-PN3, Prevenar-13, Pneumovax-23)
Recruiting
- Pneumococcal Infections
- Gamma-PN3
- +3 more
-
Adelaide, South Australia, AustraliaCMAX
Dec 29, 2022
Penile Cancer, Margin Assessment Trial in Groningen (Cetuximab-IRDye800CW)
Recruiting
- Penile Cancer
- Margin Assessment
-
Groningen, NetherlandsUniversity Medical Center Groningen
May 16, 2022
(CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of
Recruiting
- Colorectal Neoplasms
-
Maastricht, Limburg, NetherlandsMaastricht UMC+
Jan 10, 2023
Carcinoma, Renal Cell Trial in Dallas (Fitbit Versa)
Terminated
- Carcinoma, Renal Cell
- Fitbit Versa
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Feb 21, 2022
Survivors of Transplant, CREST Study
Recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Bioelectric Impedance Analysis
- +7 more
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
Mar 7, 2022
NSCLC Trial in San Antonio (bexmarilimab (FP-1305), Pembrolizumab)
Not yet recruiting
- Non-small Cell Lung Cancer
- bexmarilimab (FP-1305)
- Pembrolizumab
-
San Antonio, TexasMays Cancer Center, UT Health San Antonio
May 13, 2022